2009
DOI: 10.1590/s0066-782x2009000500018
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: The Renal Arteriovenous Fistula (RAVF) is a rare and potentially reversible cause of hypertension and kidney and/or heart failure. The treatment of RAVF aims at preserving the most of the renal parenchyma and, concomitantly, eradicating the symptoms and hemodynamic effects caused by the RAVF. The present study reports three cases of RAVF, including one case of a de novo idiopathic RAVF, which presented with hypertension and kidney and/or heart failure and describes the therapeutic measures used to treat these … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…Similarly, endovascular approaches have been used as an accepted first-line management of arteriovenous fistulas typically diagnosed post-nephrectomy by its manifestation as refractory hypertension and/or high-output heart failure [11] . However, their success may be limited in high-flow fistulas secondary to the potential for embolization agents to cause pulmonary or systemic embolisms as well as renal infarction [12] . Angiographic embolization has also been found useful in the treatment of renal artery pseudoaneurysms following nephron-sparing surgeries, which have a reported occurrence of 0.43–0.6% and 1.7–2.6% for laparoscopic and open surgeries, respectively [10] .…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, endovascular approaches have been used as an accepted first-line management of arteriovenous fistulas typically diagnosed post-nephrectomy by its manifestation as refractory hypertension and/or high-output heart failure [11] . However, their success may be limited in high-flow fistulas secondary to the potential for embolization agents to cause pulmonary or systemic embolisms as well as renal infarction [12] . Angiographic embolization has also been found useful in the treatment of renal artery pseudoaneurysms following nephron-sparing surgeries, which have a reported occurrence of 0.43–0.6% and 1.7–2.6% for laparoscopic and open surgeries, respectively [10] .…”
Section: Discussionmentioning
confidence: 99%